Biofrontera (BFRI) Equity Ratio (2020 - 2025)

Biofrontera's Equity Ratio history runs 6 years deep, the most recent figure standing at 0.37 for Q4 2025.

• In Q4 2025, Equity Ratio rose 82.92% year-over-year to 0.37; the TTM figure through Dec 2025 stood at 0.37 (up 82.92% YoY), while the FY2025 annual figure was 0.37, up 82.92% from the prior year.
• Equity Ratio was 0.37 for Q4 2025 at Biofrontera, up from 0.17 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.51 in Q2 2024 to a low of 1.13 in Q3 2021.
• Historically, Equity Ratio has averaged 0.12 across 5 years, with a median of 0.21 in 2021.
• The sharpest annual moves came in 2024 and 2025: Equity Ratio soared 881.26% in 2024, then plunged 156.06% in 2025.
• A 5-year view of Equity Ratio shows it stood at 0.21 in 2021, then soared by 120.27% to 0.47 in 2022, then sank by 63.43% to 0.17 in 2023, then climbed by 16.89% to 0.2 in 2024, then jumped by 82.92% to 0.37 in 2025.
• The last three Equity Ratio figures came in at 0.37 (Q4 2025), 0.17 (Q3 2025), and 0.23 (Q2 2025), per Business Quant data.